RABIES

This study tested the safety of a new rabies vaccine in 80 healthy people aged 10 to 60. Participants received the vaccine using one of two different dosing schedules. Researchers monitored for side effects for up to 6 months. The goal was to see if the vaccine is safe enough for…

This early-stage study tested two new vaccines—one for yellow fever and one for rabies—in 112 healthy adults aged 18 to 40. The main goal was to check safety and how well the vaccines trigger an immune response. Participants received either the vaccine or a placebo, and researche…

This study tested a new medicine called SYN023 to prevent rabies in people who were bitten or scratched by animals like dogs or bats. About 448 adults with different levels of rabies risk received either SYN023 or the standard rabies immune globulin, along with the rabies vaccine…

This study tested a new rabies vaccine in over 1,700 healthy children and adults in Thailand. The goal was to see if the new vaccine works as well as current rabies vaccines when given before exposure to the virus. Participants received either the new vaccine or one of two standa…

This study surveyed 214 Egyptian doctors (emergency, family, and surgeons) to see how well they follow official anti-rabies guidelines after animal bites. Doctors answered 10 real-life scenarios to measure their knowledge. The goal is to find where practice falls short, which can…